Skip to main content
. 2011 Sep 21;5:1359–1367. doi: 10.2147/OPTH.S23518

Figure 1.

Figure 1

Integrated microbiological eradication rates for isolates from eyes treated with besifloxacin ophthalmic suspension, 0.6%, moxifloxacin ophthalmic solution, 0.5%, or vehicle. Visit 2 took place on day 4 (±1)16 or day 5 (±1)17,18 of study treatment; visit 3 took place on day 8 or 9.16–18